Ephedra Imports Legal While Nutraceutical Appeal Underway – Emord
This article was originally published in The Tan Sheet
Executive Summary
FDA's refusal to allow Hong Kong-based broker EMAX to import ephedra-containing dietary supplements into the U.S. violates an April 2005 court ruling which invalidated the agency's ban on the botanical, according to a lawsuit filed April 21 by the firm Emord & Associates
You may also be interested in...
FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates
FDA Must Clarify Ephedra Case Impact – Supplement Trade Groups
FDA needs to "act promptly to address issues raised" by the recent Utah federal court decision that challenged aspects of the agency's ban on ephedra, leading supplement trade groups state in a joint letter to the agency
Utah Court Overturns Ephedra Ban For Low-Dose Products
A Utah federal court has barred FDA from enforcing its ban on ephedra products containing 10 mg or less of ephedrine alkaloids per daily dose